VolitionRx Limited (VNRX)
NYSE · Healthcare
VolitionRx Limited Shareholder Equity 2011–2025
VolitionRx Limited annual shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- VolitionRx Limited shareholder equity as of December 31, 2025: -34.2M, a 37.49% increase year-over-year.
- VolitionRx Limited shareholder equity for 2025 were -34.2M, a 37.49% increase from 2024.
- VolitionRx Limited shareholder equity for 2024 were -24.9M, a 219.24% increase from 2023.
- VolitionRx Limited shareholder equity for 2023 were -7.8M, a 203.00% increase from 2022.
- VolitionRx Limited shareholder equity for 2022 were -2.6M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| VolitionRx Limited Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-34 |
| 2024 | $-25 |
| 2023 | $-8 |
| 2022 | $-3 |
| 2021 | $18 |
| 2020 | $16 |
| 2019 | $14 |
| 2014 | $0 |
| 2012 | $1 |
| 2011 | $1 |
VolitionRx Limited Shareholder Equity — FAQ
VolitionRx Limited (VNRX) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VNRX's shareholder equity history?
The chart and table above show VolitionRx Limited's shareholder equity by year and by quarter, including the growth rate.